Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
In 2025, we reviewed our 2023-2025 Compliance Priorities and re-aligned our approach to focus on five core compliance principles, each supported by routinely reviewed priority focus areas. These principles guide compliance activities across all relevant areas of the TGA. More information about this change is available in our media release.
The information below sets out the five compliance principles and priority focus areas for compliance activities relating to the import, export, supply, manufacture and advertising requirements of the Therapeutic Goods Act 1989 for the period 1 January 2026 to 31 December 2027.
Our compliance principles should be read together with our Regulatory Compliance Framework, which describes our approach to compliance, including how we encourage compliance and how we respond to alleged contraventions of the law.
Priority focus areas will be reviewed every quarter and updated as required. Quarterly reviews ensure that focus areas remain current. Any updates to focus areas will be based on emerging or ongoing risks to public health and safety, and on data and intelligence from our regulatory compliance activities.
